3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Lymphoma, B-Cell, Marginal Zone
2
Pancreatic Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
Dexamethasone
17
Lenalidomide
15
Bortezomib
12
Cyclophosphamide
7
fludarabine
6
carfilzomib
6
Melphalan
6
daratumumab
5
Calcium Dobesilate
5
pomalidomide
3
gamma-Globulins
3
fludarabine phosphate
3
belantamab mafodotin
3
Whole-Body Irradiation
3
Trimethoprim, Sulfamethoxazole Drug Combination
3
Tacrolimus
3
Mycophenolic Acid
3
isatuximab
2
elotuzumab
2
Sirolimus
2
Prednisone
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Ciprofloxacin
2
Amoxicillin-Potassium Clavulanate Combination
2
venetoclax
1
thymoglobulin
1
siltuximab
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Maintenance
×
1 year
×
Clear all
No trials found.